1. Home
  2. SOC vs ALMR Comparison

SOC vs ALMR Comparison

Compare SOC & ALMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SOC

Sable Offshore Corp.

HOLD

Current Price

$4.38

Market Cap

1.6B

Sector

N/A

ML Signal

HOLD

Logo Alamar Biosciences Inc. Common Stock

ALMR

Alamar Biosciences Inc. Common Stock

N/A

Current Price

$27.28

Market Cap

1.5B

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
SOC
ALMR
Founded
2020
N/A
Country
United States
United States
Employees
200
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.5B
IPO Year
N/A
2026

Fundamental Metrics

Financial Performance
Metric
SOC
ALMR
Price
$4.38
$27.28
Analyst Decision
Buy
Analyst Count
4
0
Target Price
$17.33
N/A
AVG Volume (30 Days)
16.6M
393.7K
Earning Date
05-14-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$73.55
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.88
$21.58
52 Week High
$32.18
$29.43

Technical Indicators

Market Signals
Indicator
SOC
ALMR
Relative Strength Index (RSI) 28.94 67.81
Support Level $3.55 $24.26
Resistance Level $7.42 $28.68
Average True Range (ATR) 0.60 2.00
MACD 0.02 0.15
Stochastic Oscillator 26.23 68.24

Price Performance

Historical Comparison
SOC
ALMR

About SOC Sable Offshore Corp.

Sable Offshore Corp is a Houston-based independent upstream company focused on developing the Santa Ynez Unit in federal waters offshore California. The company operates as one reportable oil and gas segment and is engaged in the acquisition, development, exploration, and production of oil and natural gas.

About ALMR Alamar Biosciences Inc. Common Stock

Alamar Biosciences Inc is a proteomics company engaged in protein detection and analysis. The company has developed its own NULISA (NUcleic Acid Linked Immuno-Sandwich Assay) technology as the foundation of its Precision Proteomics platform enabling the detection and quantification of protein biomarkers in a single sample with ultra-high sensitivity and high specificity, even from very small volumes of biofluid. The company operates in single segment and focuses on developing a good sensitive proteomic liquid biopsy platform and sells instruments, consumables, and services based on this platform to enable early detection of diseases. The products of the company includes NULISAseq Panels, NULISAqpcr Assays, and others.

Share on Social Networks: